T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
ESCO Technologies
ESE
$7.85B
| $238M | 0.03% |
2,876,526
-30,763
| -1% | -$2.26M |
|
427
Bankunited
BKU
$3.4B
| $237M | 0.03% |
7,026,258
-56,639
| -0.8% | -$1.95M |
|
428
CNA Financial
CNA
$13.7B
| $237M | 0.03% |
5,028,685
-286,351
| -5% | -$13M |
|
429
RBC Bearings
RBC
$17.6B
| $236M | 0.03% |
1,414,424
-213,611
| -13% | -$30.2M |
|
430
3M
MMM
$95B
| $235M | 0.03% |
1,622,587
+17,376
| +1% | +$2.67M |
|
|
CUB
431
DELISTED
Cubic Corporation
CUB
| $233M | 0.03% |
3,616,217
-6,711
| -0.2% | -$394K |
|
432
Valvoline
VVV
$4.25B
| $233M | 0.03% |
11,929,741
-765,206
| -6% | -$14.1M |
|
433
Vodafone
VOD
$37.1B
| $229M | 0.03% |
14,029,325
+30,249
| +0.2% | +$520K |
|
434
Devon Energy
DVN
$49.4B
| $229M | 0.03% |
8,032,588
+5,755,255
| +253% | +$171M |
|
435
Lazard
LAZ
$4.27B
| $228M | 0.03% |
6,638,704
+698,677
| +12% | +$25M |
|
436
IBM
IBM
$222B
| $228M | 0.03% |
1,729,604
+6,266
| +0.4% | +$823K |
|
437
Southern Copper
SCCO
$164B
| $226M | 0.03% |
6,359,376
+845,573
| +15% | +$29.1M |
|
438
Allegion
ALLE
$14.2B
| $226M | 0.03% |
2,046,543
-4,722,657
| -70% | -$472M |
|
439
Alexandria Real Estate Equities
ARE
$8.32B
| $223M | 0.03% |
1,583,536
+38,475
| +2% | +$5.56M |
|
440
American Express
AXP
$232B
| $223M | 0.03% |
1,805,313
+12,355
| +0.7% | +$1.45M |
|
441
Western Digital
WDC
$157B
| $221M | 0.03% |
6,135,106
+463,773
| +8% | +$15.9M |
|
442
Archer Daniels Midland
ADM
$38.5B
| $220M | 0.03% |
5,402,967
-536,286
| -9% | -$22.2M |
|
443
Sea Limited
SE
$79.1B
| $220M | 0.03% |
6,635,427
+3,615,393
| +120% | +$98M |
|
444
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $220M | 0.03% |
3,824,824
+230,361
| +6% | +$13M |
|
|
GBT
445
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $220M | 0.03% |
4,176,942
+572,808
| +16% | +$32.9M |
|
446
Kohl's
KSS
$2.18B
| $217M | 0.03% |
4,574,025
+808,197
| +21% | +$48.8M |
|
447
Chesapeake Utilities
CPK
$3.24B
| $217M | 0.03% |
2,281,339
+43,274
| +2% | +$4.01M |
|
448
Prudential Financial
PRU
$42.3B
| $217M | 0.03% |
2,145,907
-1,179,117
| -35% | -$118M |
|
|
EQC
449
DELISTED
Equity Commonwealth
EQC
| $215M | 0.03% |
6,618,409
-1,515,353
| -19% | -$49.2M |
|
|
AVNS
450
DELISTED
Avanos Medical
AVNS
| $215M | 0.03% |
4,925,972
-23,466
| -0.5% | -$1M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.